imidazole has been researched along with sb 203580 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, S; Kikuchi, H; Shibazaki, M; Takeuchi, T | 1 |
Chen, SS; Chung, JG; Kang, SE; Ko, JL; Lin, HT; Lin, ML; Lu, YC; Tang, CH; Wang, SG | 1 |
Chai, CL; Jürjens, G; Laco, F; Low, JL; Oh, S; Reuveny, S; Seayad, J; Seow, J; Ting, S | 1 |
3 other study(ies) available for imidazole and sb 203580
Article | Year |
---|---|
Suppression by p38 MAP kinase inhibitors (pyridinyl imidazole compounds) of Ah receptor target gene activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the possible mechanism.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Chromatin; Cytochrome P-450 CYP1A1; Dioxins; Enzyme Inhibitors; Genes, Reporter; Histones; Humans; Imidazoles; Mice; Mitogen-Activated Protein Kinases; Models, Chemical; p38 Mitogen-Activated Protein Kinases; Plasmids; Precipitin Tests; Pyridines; Receptors, Aryl Hydrocarbon; RNA; RNA, Messenger; Time Factors; Transcription, Genetic; Transfection | 2004 |
Down-regulation of MMP-2 through the p38 MAPK-NF-kappaB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion.
Topics: Anthraquinones; CDC2 Protein Kinase; Cell Cycle; Cyclin B1; Down-Regulation; Humans; Imidazoles; Matrix Metalloproteinase 2; Nasopharyngeal Neoplasms; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction | 2010 |
Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells.
Topics: Cell Differentiation; Embryonic Stem Cells; Humans; Imidazoles; Mitogen-Activated Protein Kinase 14; Myocytes, Cardiac; Protein Binding; Pyridines | 2013 |